Pfizer and BioNTech announced Thursday that their COVID-19 vaccine was 91.3% effective at protecting against symptomatic disease up to six months after the second dose, with no serious safety concerns, according to an updated analysis of clinical trial results.
New data from the CDC shows a surprising number of Americans are skipping out on their second dose of the Pfizer and Moderna..
According to L.A. County health officials, people who have been fully vaccinated — meaning two weeks out from their second dose..
